AU
UK
CA
NZ
IND
US
Indivior (NASDAQ:INDV) has earned a consensus rating of "Buy" from the five brokerages that are presently covering the stock, according to Reuters. Four research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. …
ImageneBio, Inc. (Nasdaq: IMA) will commence trading on the Nasdaq Capital Market at market open on July 28, 2025, following the completed merger between Inmagene Biopharmaceuticals and Ikena Oncology, Inc. The combined clinical-stage biotechnology company will continue its focus on immunological and inflammatory diseases, …
Jefferies has upgraded Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) fromHoldtoBuywhile marginally lowering its price target to USD6 from USD6.25, according to a recent note issued ahead of the company’s upcoming second-quarter earnings report. Despite a modest downward adjustment in valuation, the firm’s updated stance …
AstraZeneca PLC (NASDAQ: AZN) has received a consensus recommendation of “Moderate Buy” from the six analysts currently covering the stock, according to a recent report byMarketBeat.com. Among them, one issued a "Hold" rating while five analysts rated the stock a "Buy". The average 12-month …
COMPASS Pathways plc (NASDAQ: CMPS), a clinical-stage mental health care company, received renewed attention from analysts this week after HC Wainwright reaffirmed its “Buy” rating on the stock. The firm maintained its ambitious price target of USD 45.00, based on expectations surrounding the development …
Shares of Verona Pharma PLC American Depositary Share (NASDAQ: VRNA) continue to trade near record highs, with analysts offering a mixed outlook for the clinical-stage biopharmaceutical firm. HC Wainwright reiterated its “Neutral” rating on Verona in a note issued Monday, raising its price target …
Longevity Health Holdings, Inc. (Nasdaq:XAGE) disclosed on July 14, 2025, that it has entered into a definitive all-stock merger agreement with THPlasma, a company engaged in plasma collection under the True Health Inc. umbrella. The transaction values THPlasma at USD 59 million, with an …
NovoCure Limited (NASDAQ: NVCR) has drawn a varied response from analysts, as its stock continues to trade at a discount compared to its 52-week high. On Tuesday, MarketBeat Ratings reported that LADENBURG THALM/SH SH reiterated a “Buy” rating for the medical equipment company and …
Haleon (LSE/NYSE: HLN) has broken ground on its newGBP130 million Global Oral Health Innovation Centrein Weybridge, Surrey. The project marks a significant step in the company’s expansion of its oral health research and development infrastructure. Once completed, the centre will act as a hub …
Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE) announced the publication of new discoveries featured on the cover ofScience. The article,“Mining the CRBN Target Space Redefines Rules for Molecular Glue-induced Neosubstrate Recognition,”presents how Monte Rosa’s AI and machine learning engine uncovered a broad range of human …
Please wait processing your request...